Sanjiban Pharma

• Multiple Myeloma: Treatment for this type of bone marrow cancer, both in newly diagnosed patients (often in combination with other drugs like melphalan, prednisone, and dexamethasone) and in those whose cancer has returned after previous treatments.
• Mantle Cell Lymphoma: Treatment for this less common, fast-growing type of non-Hodgkin lymphoma, typically in patients who have received at least one prior therapy, often as part of a combination regimen. 

Additional Information:

• Delivery Time: with in GMC half an hour
• Packaging Details: Box

Bortezomib injection is used to treat multiple myeloma (blood plasma cell cancer) in patients with or without a previous history of treatment, and mantle cell lymphoma. Bortezomib is an antineoplastic agent (cancer medicine). It interferes with the growth of cancer cells, which are eventually destroyed by the body.
Bortezomib is used to treat multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system). Bortezomib is in a class of medications called proteasome inhibitors.